BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28327285)

  • 1. [Epigenetic regulation of gene expression in malignant melanoma].
    Laurette P; Koludrovic D; Coassolo S; Davidson I
    Biol Aujourdhui; 2016; 210(4):283-295. PubMed ID: 28327285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
    Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
    Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
    Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
    Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
    Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
    J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.
    Eliades P; Abraham BJ; Ji Z; Miller DM; Christensen CL; Kwiatkowski N; Kumar R; Njauw CN; Taylor M; Miao B; Zhang T; Wong KK; Gray NS; Young RA; Tsao H
    J Invest Dermatol; 2018 Jul; 138(7):1582-1590. PubMed ID: 29408204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
    Laurette P; Strub T; Koludrovic D; Keime C; Le Gras S; Seberg H; Van Otterloo E; Imrichova H; Siddaway R; Aerts S; Cornell RA; Mengus G; Davidson I
    Elife; 2015 Mar; 4():. PubMed ID: 25803486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
    Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
    Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
    Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
    Primot A; Mogha A; Corre S; Roberts K; Debbache J; Adamski H; Dreno B; Khammari A; Lesimple T; Mereau A; Goding CR; Galibert MD
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):93-102. PubMed ID: 19895547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.
    Choi H; Jin SH; Han MH; Lee J; Ahn S; Seong M; Choi H; Han J; Cho EG; Lee TR; Noh M
    J Dermatol Sci; 2014 Oct; 76(1):60-6. PubMed ID: 25128984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
    Schepsky A; Bruser K; Gunnarsson GJ; Goodall J; Hallsson JH; Goding CR; Steingrimsson E; Hecht A
    Mol Cell Biol; 2006 Dec; 26(23):8914-27. PubMed ID: 17000761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
    Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
    Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX5 is involved in balanced MITF regulation in human melanoma cells.
    Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
    BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

  • 18. The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor.
    Coe EA; Tan JY; Shapiro M; Louphrasitthiphol P; Bassett AR; Marques AC; Goding CR; Vance KW
    PLoS Genet; 2019 Dec; 15(12):e1008501. PubMed ID: 31881017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent mutations in the MITF pathway in melanoma.
    Cronin JC; Wunderlich J; Loftus SK; Prickett TD; Wei X; Ridd K; Vemula S; Burrell AS; Agrawal NS; Lin JC; Banister CE; Buckhaults P; Rosenberg SA; Bastian BC; Pavan WJ; Samuels Y
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):435-44. PubMed ID: 19422606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
    Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
    Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.